[Thymopentin and cervico-vaginal HPV infection associated with CIN]
- PMID: 7478094
[Thymopentin and cervico-vaginal HPV infection associated with CIN]
Abstract
46 patients affected by HPV+CIN were treated with Thymopentin i.m. HPV disappeared in all cases. We also observed complete disappearance or only a partial remission of CIN in 82.6% of cases.
Similar articles
-
[beta-Interferon in the therapy of cervico-vaginal papilloma virus (HPV) infection associated with cervical intraepithelial neoplasia (CIN)].Minerva Ginecol. 1995 Dec;47(12):527-9. Minerva Ginecol. 1995. PMID: 8720973 Clinical Trial. Italian.
-
[Role of immunomodulatory treatment with Iscador QuS and Intron A of women with CIN1 with concurrent HPV infection].Ginekol Pol. 2003 Sep;74(9):729-35. Ginekol Pol. 2003. PMID: 14674116 Clinical Trial. Polish.
-
[Intra-lesional beta-interferon in combination with systemic thymopentin. Evaluation of results in 35 cases of CIN III and 2 cases of VAIN associated with HPV].Minerva Ginecol. 1990 Apr;42(4):123-8. Minerva Ginecol. 1990. PMID: 2163035 Review. Italian.
-
Cidofovir, a new approach for the treatment of cervix intraepithelial neoplasia grade III (CIN III).J Med Virol. 2000 Feb;60(2):205-9. doi: 10.1002/(sici)1096-9071(200002)60:2<205::aid-jmv16>3.0.co;2-8. J Med Virol. 2000. PMID: 10596022 Clinical Trial.
-
Lower genital tract intraepithelial neoplasia in HIV-infected women: guidelines for evaluation and management.Obstet Gynecol Surv. 1999 Feb;54(2):131-7. doi: 10.1097/00006254-199902000-00023. Obstet Gynecol Surv. 1999. PMID: 9950005 Review.
Cited by
-
Thymopentin and splenopentin as immunomodulators. Current status.Immunol Res. 1998;17(3):345-68. doi: 10.1007/BF02786456. Immunol Res. 1998. PMID: 9638477 Review.